The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 25, 2025

Filed:

Aug. 17, 2021
Applicant:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Inventors:

Denise Zarins, Los Gatos, CA (US);

Benjamin J. Clark, Redwood City, CA (US);

Nicolas Zadno, Fremont, CA (US);

Hanson S. Gifford, III, Woodside, CA (US);

Erik Thai, Mountain View, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61B 18/12 (2006.01); A61B 18/14 (2006.01); A61M 5/14 (2006.01); A61M 37/00 (2006.01); A61N 1/05 (2006.01); A61N 1/32 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 18/1477 (2013.01); A61B 18/1206 (2013.01); A61M 5/14 (2013.01); A61M 37/00 (2013.01); A61N 1/05 (2013.01); A61N 1/0514 (2013.01); A61N 1/0551 (2013.01); A61N 1/321 (2013.01); A61N 1/327 (2013.01); A61N 1/36007 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00505 (2013.01); A61B 2018/00613 (2013.01); A61B 2018/126 (2013.01);
Abstract

Methods and apparatus are provided for pulsed electric field (PEF) neuromodulation via an intra-to-extravascular approach, e.g., to effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, changes in cytokine upregulation and other conditions in target neural fibers. In some embodiments, an apparatus includes an intravascular catheter having one or more electrodes configured for intra-to-extravascular placement across a wall of patient's vessel into proximity with target neural fibers. With the electrode(s) passing from an intravascular position to an extravascular position prior to delivery of the PEF, a magnitude of applied voltage or energy delivered via the electrode(s) and necessary to achieve desired neuromodulation may be reduced relative to an intravascular PEF system having one or more electrodes positioned solely intravascularly. The methods and apparatus may, for example, be used to modulate one or more target neural fibers that contribute to renal function.


Find Patent Forward Citations

Loading…